p63 the guardian of human reproduction

p63 is a transcriptional factor implicated in cancer and development. The presence in TP63 gene of alternative promoters allows expression of one isoform containing the N-terminal transactivation domain (TA isoform) and one N-terminal truncated isoform (ΔN isoform). Complete ablation of all p63 isoforms produced mice with fatal developmental abnormalities, including lack of epidermal barrier, limbs and other epidermal appendages. Specific TAp63-null mice, although they developed normally, failed to undergo in DNA damage-induced apoptosis during primordial follicle meiotic arrest, suggesting a p63 involvement in maternal reproduction. Recent findings have elucidated the role in DNA damage response of a novel Hominidae p63 isoform, GTAp63, specifically expressed in human spermatic precursors. Thus, these findings suggest a unique strategy of p63 gene, to evolve in order to preserve the species as a guardian of reproduction. Elucidation of the biological basis of p63 function in reproduction may provide novel approaches to the control of human fertility.

[1]  A. Strasser,et al.  DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. , 2012, Molecular cell.

[2]  I. Amelio,et al.  miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration , 2012, The Journal of cell biology.

[3]  A. Levine,et al.  Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer , 2012, Proceedings of the National Academy of Sciences.

[4]  G. Cesareni,et al.  Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib , 2012, Nature Medicine.

[5]  T. Speed,et al.  Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib , 2012, Nature Medicine.

[6]  P. Tucci Caloric restriction: is mammalian life extension linked to p53? , 2012, Aging.

[7]  S. Melov,et al.  cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad , 2012, Aging.

[8]  V. Smits EDD induces cell cycle arrest by increasing p53 levels , 2012, Cell cycle.

[9]  S. Sinha,et al.  ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2012, Development.

[10]  M. Olivier,et al.  Biological functions of p53 isoforms through evolution: lessons from animal and cellular models , 2011, Cell Death and Differentiation.

[11]  A. Mahdi,et al.  Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor , 2011, Oncotarget.

[12]  J. McCubrey,et al.  Recent progress in targeting cancer , 2011, Aging.

[13]  C. Montagna,et al.  Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors , 2011, Oncotarget.

[14]  M. Baccarani,et al.  Imatinib in chronic myeloid leukemia elderly patients , 2011, Aging.

[15]  U. Moll,et al.  SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis , 2011, Cell Death and Differentiation.

[16]  B. Joseph,et al.  TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death , 2011, Oncotarget.

[17]  David F. Callen,et al.  Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome , 2011, Oncotarget.

[18]  P. Madureira,et al.  DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death , 2011, Oncotarget.

[19]  I. Amelio,et al.  The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles. , 2011, Biochemical pharmacology.

[20]  G. Melino,et al.  Cell death pathology: perspective for human diseases. , 2011, Biochemical and biophysical research communications.

[21]  I. Amelio,et al.  Cell death pathology: cross-talk with autophagy and its clinical implications. , 2011, Biochemical and biophysical research communications.

[22]  M. Napoli,et al.  Wiring the oncogenic circuitry: Pin1 unleashes mutant p53 , 2011, Oncotarget.

[23]  C. Chien,et al.  The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? , 2011, Cell Death and Differentiation.

[24]  M. Dobbelstein,et al.  Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon , 2011, Cell cycle.

[25]  V. Dötsch,et al.  Quality control in oocytes: Domain-domain interactions regulate the activity of p63 , 2011, Cell cycle.

[26]  H. Tseng,et al.  Intracellular zinc release-activated ERK-dependent GSK-3β–p53 and Noxa–Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury , 2011, Cell Death and Differentiation.

[27]  L. Mayo,et al.  ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization , 2011, Cell Death and Differentiation.

[28]  M. Jiang,et al.  SUMO-specific protease 2 in Mdm2-mediated regulation of p53 , 2011, Cell Death and Differentiation.

[29]  A. Jochemsen,et al.  Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX , 2011, Cell Death and Differentiation.

[30]  R. Mantovani,et al.  NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table , 2011, Cell Death and Disease.

[31]  U. Moll,et al.  Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors , 2011, Cell Death and Disease.

[32]  G. Melino,et al.  ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis , 2011, Cell Death and Differentiation.

[33]  L. Zhang,et al.  Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways , 2011, Cell Death and Differentiation.

[34]  B. Pützer,et al.  GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria , 2011, Cell Death and Differentiation.

[35]  R. Jänicke,et al.  Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21WAF1/CIP1 , 2011, Cell Death and Differentiation.

[36]  A. Furlan,et al.  Abl interconnects oncogenic Met and p53 core pathways in cancer cells , 2011, Cell Death and Differentiation.

[37]  B. Kim,et al.  PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation , 2011, Cell Death and Differentiation.

[38]  S. de Jong,et al.  Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway , 2011, Cell Death and Disease.

[39]  A. Holoubek,et al.  Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA , 2011, Molecular and Cellular Biochemistry.

[40]  A. Ciechanover,et al.  Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms , 2011, Cell Death and Differentiation.

[41]  L. Ellisen,et al.  A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity , 2011, Oncotarget.

[42]  Aubrey E. Hill,et al.  Spontaneous inactivating p53 mutations and the “selfish cell” , 2011, Aging.

[43]  Yanping Zhang,et al.  The RP-Mdm2-p53 Pathway and Tumorigenesis , 2011, Oncotarget.

[44]  S. Knapp,et al.  DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer , 2011, Cell.

[45]  U. Moll,et al.  Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes , 2011, Proceedings of the National Academy of Sciences.

[46]  M. Blagosklonny Cell cycle arrest is not senescence , 2011, Aging.

[47]  K. Sabapathy,et al.  Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo , 2011, Cell Death and Differentiation.

[48]  D. Lane,et al.  p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage , 2011, Cell Death and Differentiation.

[49]  E. Rodríguez-Aznar,et al.  Repression of Puma by Scratch2 is required for neuronal survival during embryonic development , 2011, Cell Death and Differentiation.

[50]  V. Graupner,et al.  Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level , 2011, Cell Death and Differentiation.

[51]  W. B. Derry,et al.  The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans , 2011, Cell Death and Differentiation.

[52]  J. Luk,et al.  Mortalin–p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy , 2011, Cell Death and Differentiation.

[53]  V. Dulic,et al.  Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence? , 2011, Aging.

[54]  G. D’Orazi,et al.  HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation , 2011, Aging.

[55]  C. Harris,et al.  p53 governs telomere regulation feedback too, via TRF2 , 2011, Aging.

[56]  Antoine M. van Oijen,et al.  A single-molecule characterization of p53 search on DNA , 2010, Proceedings of the National Academy of Sciences.

[57]  A. Fersht,et al.  Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA , 2010, Proceedings of the National Academy of Sciences.

[58]  A. Chatterjee,et al.  Regulation of ΔNp63α by NFκΒ , 2010, Cell cycle.

[59]  N. Danial,et al.  Noxa: a sweet twist to survival and more. , 2010, Molecular cell.

[60]  Seung-Moo Noh,et al.  Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. , 2010, The Journal of clinical investigation.

[61]  Yiping Huang,et al.  Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells , 2010, Aging.

[62]  Anton Berns,et al.  Cancer: The blind spot of p53 , 2010, Nature.

[63]  Youngho Seo,et al.  Selective activation of p53-mediated tumour suppression in high-grade tumours , 2010, Nature.

[64]  P. Hau,et al.  The requirement of p53 for maintaining chromosomal stability during tetraploidization , 2010, Oncotarget.

[65]  A. Villunger,et al.  PUMA-mediated tumor suppression: A tale of two stories , 2010, Cell cycle.

[66]  Wei Gu,et al.  p53 post-translational modification: deregulated in tumorigenesis. , 2010, Trends in molecular medicine.

[67]  I. Amelio,et al.  Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression. , 2010, Biochemical and biophysical research communications.

[68]  Wenyi Wei,et al.  Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction , 2010, Oncotarget.

[69]  Francisco J. Sánchez-Rivera,et al.  Stage-specific sensitivity to p53 restoration during lung cancer progression , 2010, Nature.

[70]  K. Tanaka,et al.  Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus , 2010, Cell Death and Disease.

[71]  F. Gage,et al.  Puma is required for p53-induced depletion of adult stem cells , 2010, Nature Cell Biology.

[72]  D. Trinh,et al.  Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis , 2010, Oncotarget.

[73]  D. Trinh,et al.  Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosisy as a Target for Cancer Therapy , 2010 .

[74]  M. Pajic,et al.  Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo , 2010, Cell cycle.

[75]  Y. Shyr,et al.  Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation , 2010, Cell Death and Disease.

[76]  H. Ananthaswamy,et al.  Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence , 2010, Cell cycle.

[77]  K. Ryan,et al.  Phosphorylation of Puma modulates its apoptotic function by regulating protein stability , 2010, Cell Death and Disease.

[78]  Frédérick A. Mallette,et al.  SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence , 2010, Aging.

[79]  Z. Darżynkiewicz Another "Janus paradox" of p53: induction of cell senescence versus quiescence , 2010, Aging.

[80]  G. Sal,et al.  p53-family proteins and their regulators: hubs and spokes in tumor suppression , 2010, Cell Death and Differentiation.

[81]  G. Nilsson,et al.  Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosis , 2010, Cell Death and Disease.

[82]  V. Sée,et al.  p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma , 2010, Cell Death and Disease.

[83]  Michael Hölzel,et al.  The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword , 2010, Oncotarget.

[84]  R. Knight,et al.  p73 and p63 regulate the expression of fibroblast growth factor receptor 3. , 2010, Biochemical and biophysical research communications.

[85]  C. Brisken,et al.  Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates , 2010, Cell Death and Differentiation.

[86]  S. Kumar,et al.  A potential role for NEDD1 and the centrosome in senescence of mouse embryonic fibroblasts , 2010, Cell Death and Disease.

[87]  I. B. Borel Rinkes,et al.  Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa , 2010, British Journal of Cancer.

[88]  K. Vousden,et al.  p53-mediated induction of Noxa and p53AIP1 requires NFκB , 2010 .

[89]  A. Knebel,et al.  JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis , 2010, Cell Death and Disease.

[90]  N. Reich,et al.  Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding , 2010, Cell Death and Differentiation.

[91]  A. Tedeschi,et al.  HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation , 2010, Cell Death and Differentiation.

[92]  E. Candi,et al.  The microRNA and p53 families join forces against cancer , 2010, Cell Death and Differentiation.

[93]  J. Prehn,et al.  BH3-only proteins BIM and PUMA in the regulation of survival and neuronal differentiation of newly generated cells in the adult mouse hippocampus , 2010, Cell Death and Disease.

[94]  Nektarios Tavernarakis,et al.  Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy , 2010, Cell Death and Disease.

[95]  G. Cesareni,et al.  Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death , 2009, Nature Medicine.

[96]  L. Zhang,et al.  IRF-1 transcriptionally up-regulates PUMA which mediates the mitochondrial apoptotic pathway in IRF-1 induced apoptosis in cancer cells , 2009, Cell Death and Differentiation.

[97]  Y. Liu,et al.  p53 regulates hematopoietic stem cell quiescence. , 2009, Cell stem cell.

[98]  Yiping Huang,et al.  ATM kinase is a master switch for the ΔNp63α phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage , 2008 .

[99]  Hua Lu,et al.  Phosphorylation and Stabilization of TAp63γ by IκB Kinase-β* , 2008, Journal of Biological Chemistry.

[100]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[101]  F. McKeon,et al.  p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.

[102]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[103]  G. Livera,et al.  The role of p63 in germ cell apoptosis in the developing testis , 2007, Journal of cellular physiology.

[104]  M. Kretz,et al.  p63 regulates proliferation and differentiation of developmentally mature keratinocytes. , 2006, Genes & development.

[105]  A. Yang,et al.  p63 protects the female germ line during meiotic arrest , 2006, Nature.

[106]  C. Croce,et al.  The E3 ubiquitin ligase Itch controls the protein stability of p63 , 2006, Proceedings of the National Academy of Sciences.

[107]  D. Lane,et al.  p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress , 2006, Cell Death and Differentiation.

[108]  J. Mestan,et al.  Allosteric inhibitors of Bcr-abl–dependent cell proliferation , 2006, Nature chemical biology.

[109]  G. Livera,et al.  p63 expression pattern in foetal and neonatal gonocytes after irradiation and role in the resulting apoptosis by using p63 knockout mice , 2006, International journal of radiation biology.

[110]  F. McKeon,et al.  DNA-Binding and Transactivation Activities Are Essential for TAp63 Protein Degradation , 2005, Molecular and Cellular Biology.

[111]  O. Hovatta,et al.  Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. , 2005, Reproduction.

[112]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[113]  W. B. Derry,et al.  Caenorhabditis elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance , 2001, Science.

[114]  M. Belvin,et al.  Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53 , 2000, Cell.

[115]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[116]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[117]  Gerry Melinoa,et al.  Loss of p 63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer , 2014 .

[118]  P. Madureira,et al.  binding to p 53 on the p 21 WAF 1 / CIP 1 promoter blocks transcription resulting in cell death , 2012 .

[119]  Y. Shaul,et al.  c-Abl tyrosine kinase in the DNA damage response: cell death and more , 2011, Cell Death and Differentiation.

[120]  David P. Lane,et al.  Translating p53 into the clinic , 2010, Nature Reviews Clinical Oncology.

[121]  W. Gu,et al.  The multiple levels of regulation by p53 ubiquitination , 2010, Cell Death and Differentiation.

[122]  Y. Shaul,et al.  Ubiquitin-independent p53 proteasomal degradation , 2010, Cell Death and Differentiation.

[123]  J. Marine,et al.  Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.

[124]  Yiping Huang,et al.  ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. , 2008, Cell cycle.

[125]  R. Wurm,et al.  Normal tissue radiosensitivity--how important is it? , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[126]  S. Sinha,et al.  Np 63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2022 .

[127]  A. Bradley,et al.  p 63 is a p 53 homologue required for limband epidermalmorphogenesis , 2022 .